Trials / Suspended
SuspendedNCT03101098
Retroperitoneal Ligation of Uterine Artery in Total Laparoscopic Hysterectomy for Enlarged Uterus
Retroperitoneal Ligation of Uterine Artery in Total Laparoscopic Hysterectomy for Enlarged Uterus: A Randomized Controlled Trial
- Status
- Suspended
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 54 (estimated)
- Sponsor
- Kangbuk Samsung Hospital · Academic / Other
- Sex
- Female
- Age
- 19 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This randomized trial is aimed to investigate the role of retroperitoneal TLH in enlarge uterus.
Detailed description
Laparoscopic hysterectomy is one of the most common gynecologic surgeries worldwide. Generally, in total laparoscopic hysterectomy (TLH), uterine arteries are coagulated or transected close to the uterus, alongside the cervix, like surgical technique of a conventional total abdominal hysterectomy. Recently, several studies showed that ligation of uterine artery where it originates from the internal iliac artery during TLH (so-called "retroperitoneal TLH") is effective for reducing blood loss. However, the application of this technique to clinical practice have not been well investigated in terms of its efficacy and safety. Moreover, most of the previous studies on retroperitoneal TLH were small case series or retrospective comparative studies with conventional TLH. Therefore, the investigators conducted this randomized trial to investigate the role of retroperitoneal TLH in enlarge uterus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Retroperitoneal liagation of uterine artery | the site of ligation of uterine artery is the area that it originates from the internal iliac artery during TLH |
| PROCEDURE | Classical ligation of uterine artery | the site of ligation of uterine artery is the area alongside the cervix |
Timeline
- Start date
- 2017-04-10
- Primary completion
- 2020-03-01
- Completion
- 2020-03-01
- First posted
- 2017-04-04
- Last updated
- 2019-04-03
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03101098. Inclusion in this directory is not an endorsement.